CapsoCam Plus expands access to non-invasive diagnostics for children aged 2 and above.
Innovative Diagnostics for Young Patients
CapsoVision announced FDA clearance for its CapsoCam Plus system, allowing use in pediatric patients as young as two years old. This marks a significant advancement in non-invasive gastrointestinal diagnostics for children.
Features of CapsoCam Plus
- 360° Panoramic View: Equipped with four cameras, the capsule captures high-resolution, lateral images of the small bowel, enhancing visibility of abnormalities.
- No External Equipment: Unlike traditional capsule systems, CapsoCam eliminates the need for wearable devices, sensor belts, or adhesive strips.
- Streamlined Process: Pediatric patients can resume normal activities after ingestion, and the retrieval process avoids additional tests or X-rays.
- Cloud-Based Efficiency: The CapsoCloud platform enables providers to access and review diagnostic data seamlessly online, saving time and improving clinical workflows.
Improving Pediatric Endoscopy Experiences
CapsoVision designed the CapsoCam Plus with child-friendly usability in mind, addressing challenges such as discomfort, equipment malfunctions, and post-procedure logistics.
“With CapsoCam Plus, we can now provide a child-friendly solution that improves patient comfort, diagnostic accuracy, and caregiver experience,” said Johnny Wang, President and CEO.
Significance for Pediatric Care
The clearance allows clinicians to use the CapsoCam Plus system to diagnose gastrointestinal conditions in young children with a less invasive, stress-free method, improving both clinical outcomes and patient experiences.
Follow MEDWIRE.AI for updates on pediatric medical technologies and advancements in non-invasive diagnostics.
